Quantitative measurement of HER2 levels by multiplexed mass spectrometry from FFPE tissue predicts survival in patients treated with anti-HER2 based therapy

被引：0
|
作者：
Nuciforo, Paolo [1 ]
Thyparambil, Sheeno [2 ]
Aura, Claudia [1 ]
Garrido-Castro, Ana [1 ]
Peg, Vicente [1 ]
Jimenez, Jose [1 ]
Hoos, William [2 ]
Burrows, Jon [2 ]
Hembrough, Todd [2 ]
Perez-Garcia, Jose [1 ]
Cortes, Javier [1 ]
Scaltriti, Maurizio [3 ]
机构：
[1] Vall dHebron Inst Oncol, Barcelona, Spain
[2] Oncoplex Diagnost, Rockville, MD USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-11-29
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Stability of HER2 Expression in Residual Breast Cancer Following Neoadjuvant Anti-HER2 Therapy.
    Mir, Mariam O.
    Sahoo, Sunati
    Fang, Yisheng
    Peng, Yan
    Hwang, Helena
    Czapla, Agata
    Koduru, Prasad
    Sarode, Venetia
    MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [32] Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies
    Fu, Wenyan
    Wang, Yuxiao
    Zhang, Yunshan
    Xiong, Lijuan
    Takeda, Hiroaki
    Ding, Li
    Xu, Qunfang
    He, Lidong
    Tan, Wenlong
    Bethune, Augus N.
    Zhou, Lijun
    MABS, 2014, 6 (04) : 978 - 990
  • [33] Non-HER2 patients may still be targeted for anti-HER2 therapy
    Wilson, Hannah L.
    PERSONALIZED MEDICINE, 2013, 10 (02) : 120 - 121
  • [34] HER2 Low-Amplified Breast Cancer: The Efficacy of Anti-HER2 Therapy in Neoadjuvant Setting
    Lv, Hong
    Bai, Qianming
    Shui, Ruohong
    Xu, Xiaoli
    Yu, Bao-Hua
    Bi, Rui
    Cheng, Yufan
    Tu, Xiaoyu
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S177 - S178
  • [35] Anti-HER2 treatment in advanced metastatic HER2-negative breast cancer patients with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells.
    Kurbacher, Christian M.
    Eichler, Christian A.
    Quade, Annegret Barbara
    Kunstmann, Gerhard
    Herz, Susanne
    Kurbacher, Jutta Anna
    Warm, Mathias R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
    R Bartsch
    A Berghoff
    U Pluschnig
    Z Bago-Horvath
    P Dubsky
    A Rottenfusser
    C DeVries
    M Rudas
    F Fitzal
    K Dieckmann
    R M Mader
    M Gnant
    C C Zielinski
    G G Steger
    British Journal of Cancer, 2012, 106 : 25 - 31
  • [37] Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
    Bartsch, R.
    Berghoff, A.
    Pluschnig, U.
    Bago-Horvath, Z.
    Dubsky, P.
    Rottenfusser, A.
    DeVries, C.
    Rudas, M.
    Fitzal, F.
    Dieckmann, K.
    Mader, R. M.
    Gnant, M.
    Zielinski, C. C.
    Steger, G. G.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 25 - 31
  • [38] HER2 Expression in Circulating Tumor Cells as Prognostic and Predictive Biomarkers for Anti-HER2 Therapy in Previously Treated Metastatic Colorectal Cancer
    Wang, Mengting
    Xu, Ting
    Shen, Lin
    Li, Jian
    Zhu, Ling
    Wang, Chen
    Hu, Zhiyuan
    Li, Ping
    Yang, Yanlian
    Wang, Xicheng
    ADVANCED THERAPEUTICS, 2023, 6 (10)
  • [39] Non-HER2 patients might still be targeted for anti-HER2 therapy Somatic HER2 mutations identified as targets for breast cancer treatment
    Wilson, Hannah
    BREAST CANCER MANAGEMENT, 2013, 2 (02) : 94 - 95
  • [40] Anti-HER2 therapy for breast cancer in older patients
    Goldner, Marcelle
    Franzoi, Maria A.
    Lago, Lissandra D.
    Ponde, Noam
    FUTURE ONCOLOGY, 2020, 16 (19) : 1393 - 1407
12345